(Q46124617)

English

Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice

scientific article published on 11 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

0 references

1 reference

based on heuristic

inferred from title

Christophe Magnan

object named as

Christophe Magnan

7

0 references

author name string

Stéphanie Migrenne

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

Amélie Lacombe

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

Anne-Laure Lefèvre

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

Marie-Pierre Pruniaux

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

Etienne Guillot

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

Anne-Marie Galzin

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

publication date

11 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

296

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

R929-35

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Effects of rimonabant (SR141716) on fasting-induced hypothalamic-pituitary-adrenal axis and neuronal activation in lean and obese Zucker rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Activation of the peripheral endocannabinoid system in human obesity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Increased energy expenditure contributes more to the body weight-reducing effect of rimonabant than reduced food intake in candy-fed wistar rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Endocannabinoids in the regulation of appetite and body weight

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Essential role of mitochondrial function in adiponectin synthesis in adipocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Disruption of adiponectin causes insulin resistance and neointimal formation

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Endocrine functions of adipose tissue: focus on adiponectin

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Ceramides in insulin resistance and lipotoxicity

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Insulin internalizes GLUT2 in the enterocytes of healthy but not insulin-resistant mice.

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Cannabinoids and ceramide: two lipids acting hand-by-hand

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Hepatic knockdown of mitochondrial GPAT1 in ob/ob mice improves metabolic profile

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.90824.2008

21 January 2018

Identifiers

10.1152/AJPREGU.90824.2008

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/19211723

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46124617&oldid=2093839457"